Mississippi Gulf Coast Community College Nursing Program Earns Accreditation

It's the news everyone involved in the Associate Nursing Degree program at Mississippi Gulf Coast Community College was hoping for – the National League for Nursing Accrediting Commission (NLNAC) has recommended continuing accreditation for the ADN program for another eight years.

“We are thrilled,” said Nica Cason, Gulf Coast ADN chairperson. “The NLNAC was here April 19-21, and they were very thorough. But we did a great job. It's out of our hands now.”

Cason said there are two more steps before accreditation is complete. First, the NLNAC will send its recommendation to an ADN panel in June. That panel then sends its recommendation to the NLNAC commissioners in July. Cason also said that last two steps are usually just formalities.

The news comes a critical time for the ADN program. The Mississippi Department of Employment Security projects a 21 percent employment growth for licensed practical nurses (LPNs) by 2012. In fact, of the 30 fastest growing occupations, 17 are health-related.

The ADN program at Gulf Coast features locations at the three main campuses, with 353 students enrolled. Some of them said the program's continuing accreditation isn't surprising.

“It's a tough program,” said nursing student Kim Bartlett, as she studied with fellow nursing students Carrie Moran and Jeanne Nicholson. “They set the standards higher than the other schools. Making it through this takes a huge sacrifice, but it will be worth it in the end.”

“It's very intense,” Moran said. “They don't play around. I like that, because I really want to be a nurse and help people.”

“The program is affordable, and it's the quickest path to making good money,” Nicholson said.


Walden University's M.S. Program in Nursing Receives CCNE Accreditation
Eastern Nursing Graduates Earn 90% NCLEX Pass Rate
Academic Leaders Form New Global Alliance on Nursing Education to Focus on Improving Patient Care Worldwide Two Executives Convicted in Unapproved Sterilization Device Scheme
FDA Approves New Treatment for Myelodysplastic Syndromes (MDS)
FDA Approves First Treatment for Pompe Disease
Benzene in Soft Drinks
Investigation of Serious Eye Infections Associated With Soft Contact Lens Use and Contact Lens Solution
Permanent Court Order Halts Illegal Importation of Prescription Drugs
Fuld Trust Awards $2.5 Million Grant to School of Nursing


Go Back